Google is to create a brand new miniature glucometer. This revolutionary device will benefit diabetic patients around the world.
A drop of blood. A strip and a meter that reads the blood glucose levels. That is the normal routine for so many in the United States. 10% of Americans, that is 21.9 million people, have diabetes.
Don't Miss: See the first leaked Black Friday 2016 Ad
Drugs and a dietary regimen as well as an exercise routine are needed in the lives of these patients. The transformations need to get made. And that is in correspondence with the blood glucose readings on the glucometer.
Now Dexcom has hooked up with Google to produce a novel diabetes management contraption. Google’s Life Sciences Division has it all covered. Termed a Continuous Glucose Monitoring (CGM) System, it is a stickable application. You apply it to the human skin and the reading comes on a separate monitor.
"This partnership has the potential to change the face of diabetes technology forever," said Kevin Sayer, President and Chief Executive Officer of DexCom. "Working together, we believe we can introduce products that will move us beyond our core Type 1 business to become the standard of care for all people living with diabetes."
"We're committed to developing new technologies that will help move health care from reactive to proactive," said Andrew Conrad, head of the life sciences team at Google. "This collaboration is another step towards expanding monitoring options and making it easier for people with diabetes to proactively manage their health."
Dexcom’s current CGM picks up the signals from beneath the skin of the patient. And it suits both Type 1 and Type 2 diabetes patients. The trend is from reactivity to proactivity. Miniature electronics are the wave of the future. And they have made this gizmo possible.
Millions of dollars have gotten spent on the project. The future of diabetes management is at stake. And it will be successful provided everything dovetails in a smooth manner. Dexcom is a pioneer in diabetes coping systems.
The existing technologies do not equal the capacity of the joint project. Diabetes technology will never look back from this point onwards. The collaboration is a wonderful idea that has worked on a practical level.
It is a bandage-sized monitor. Glucometer and Google start with the same letter. And Dexcom and Diabetes too start with the same letter. The new system is seamless and cheap. It does not cost an arm and a leg.
The expansion of diabetes management is just a preliminary step. This project may lead onwards to robotics and other bionic means of disease prevention. It is now or never. The device is no more than a simple band-aid plastered on the arm. The procedure of blood sugar monitoring gets made as easy as apple pie.
Diabetes is a disease of civilization. Our hunting gathering ancestors didn’t know what this ailment was. The presence of refined white carbohydrates in the diet are the main culprits. And there are other factors too such as faulty genetics and stress levels.